In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
February 1st, 2009 | 20 | No |
Popular Name: dihydrexidine dihydrexidine
CPD000466286; Benzo[a]phenanthridine-10,11-diol, 5,6,6a,7,8,12b-hexahydro-, trans- [CAS]
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.38 | 2.34 | -7.4 | 3 | 3 | 0 | 52 | 267.328 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 0884; 1.75 water; 1 hydrogen chloride | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 0884; SALT: 1.75 water; 1 hydrogen chloride | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
5HT2C-1-E | Serotonin 2c (5-HT2c) Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2400 | 0.39 | Binding ≤ 10μM |
ADA2A-1-E | Alpha-2a Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 3000 | 0.39 | Binding ≤ 10μM |
ADA2B-1-E | Alpha-2b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 3000 | 0.39 | Binding ≤ 10μM |
ADA2C-1-E | Alpha-2c Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 3000 | 0.39 | Binding ≤ 10μM |
ADCY2-2-E | Adenylate Cyclase Type II (cluster #2 Of 2), Eukaryotic | Eukaryotes | 70 | 0.50 | Binding ≤ 10μM |
ADCY3-2-E | Adenylate Cyclase Type III (cluster #2 Of 2), Eukaryotic | Eukaryotes | 70 | 0.50 | Binding ≤ 10μM |
ADCY4-2-E | Adenylate Cyclase Type IV (cluster #2 Of 2), Eukaryotic | Eukaryotes | 70 | 0.50 | Binding ≤ 10μM |
ADCY5-2-E | Adenylate Cyclase Type V (cluster #2 Of 2), Eukaryotic | Eukaryotes | 70 | 0.50 | Binding ≤ 10μM |
ADCY6-2-E | Adenylate Cyclase Type VI (cluster #2 Of 2), Eukaryotic | Eukaryotes | 70 | 0.50 | Binding ≤ 10μM |
ADCY8-1-E | Adenylate Cyclase Type VIII (cluster #1 Of 2), Eukaryotic | Eukaryotes | 70 | 0.50 | Binding ≤ 10μM |
ADRB1-1-E | Beta-1 Adrenergic Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1500 | 0.41 | Binding ≤ 10μM |
ADRB2-1-E | Beta-2 Adrenergic Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1200 | 0.41 | Binding ≤ 10μM |
DRD1-1-E | Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 21 | 0.54 | Binding ≤ 10μM |
DRD3-1-E | Dopamine D3 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 170 | 0.47 | Binding ≤ 10μM |
DRD4-3-E | Dopamine D4 Receptor (cluster #3 Of 4), Eukaryotic | Eukaryotes | 13 | 0.55 | Binding ≤ 10μM |
DRD5-1-E | Dopamine D5 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 16 | 0.55 | Binding ≤ 10μM |
ADCY5-1-E | Adenylate Cyclase Type V (cluster #1 Of 1), Eukaryotic | Eukaryotes | 51 | 0.51 | Functional ≤ 10μM |
DRD1-1-E | Dopamine D1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 88 | 0.49 | Functional ≤ 10μM |
DRD1-1-E | Dopamine D1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10000 | 0.35 | Functional ≤ 10μM |
DRD2-1-E | Dopamine D2 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 70 | 0.50 | Functional ≤ 10μM |
DRD4-1-E | Dopamine D4 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 17 | 0.54 | Functional ≤ 10μM |
DRD2-2-E | Dopamine D2 Receptor (cluster #2 Of 24), Eukaryotic | Eukaryotes | 88 | 0.49 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 10000 | 0.35 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADCY2_RAT | P26769 | Adenylate Cyclase Type II, Rat | 70 | 0.50 | Binding ≤ 1μM |
ADCY3_RAT | P21932 | Adenylate Cyclase Type III, Rat | 70 | 0.50 | Binding ≤ 1μM |
ADCY4_RAT | P26770 | Adenylate Cyclase Type IV, Rat | 70 | 0.50 | Binding ≤ 1μM |
ADCY5_RAT | Q04400 | Adenylate Cyclase Type V, Rat | 140 | 0.48 | Binding ≤ 1μM |
ADCY6_RAT | Q03343 | Adenylate Cyclase Type VI, Rat | 70 | 0.50 | Binding ≤ 1μM |
ADCY8_RAT | P40146 | Adenylate Cyclase Type VIII, Rat | 70 | 0.50 | Binding ≤ 1μM |
DRD1_HUMAN | P21728 | Dopamine D1 Receptor, Human | 14 | 0.55 | Binding ≤ 1μM |
DRD1_RAT | P18901 | Dopamine D1 Receptor, Rat | 100 | 0.49 | Binding ≤ 1μM |
DRD1_PIG | P50130 | Dopamine D1 Receptor, Pig | 21 | 0.54 | Binding ≤ 1μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 107 | 0.49 | Binding ≤ 1μM |
DRD2_HUMAN | P14416 | Dopamine D2 Receptor, Human | 240 | 0.46 | Binding ≤ 1μM |
DRD3_RAT | P19020 | Dopamine D3 Receptor, Rat | 170 | 0.47 | Binding ≤ 1μM |
DRD4_RAT | P30729 | Dopamine D4 Receptor, Rat | 13 | 0.55 | Binding ≤ 1μM |
DRD5_RAT | P25115 | Dopamine D5 Receptor, Rat | 16 | 0.55 | Binding ≤ 1μM |
ADCY2_RAT | P26769 | Adenylate Cyclase Type II, Rat | 70 | 0.50 | Binding ≤ 10μM |
ADCY3_RAT | P21932 | Adenylate Cyclase Type III, Rat | 70 | 0.50 | Binding ≤ 10μM |
ADCY4_RAT | P26770 | Adenylate Cyclase Type IV, Rat | 70 | 0.50 | Binding ≤ 10μM |
ADCY5_RAT | Q04400 | Adenylate Cyclase Type V, Rat | 140 | 0.48 | Binding ≤ 10μM |
ADCY6_RAT | Q03343 | Adenylate Cyclase Type VI, Rat | 70 | 0.50 | Binding ≤ 10μM |
ADCY8_RAT | P40146 | Adenylate Cyclase Type VIII, Rat | 70 | 0.50 | Binding ≤ 10μM |
ADA2A_RAT | P22909 | Alpha-2a Adrenergic Receptor, Rat | 3000 | 0.39 | Binding ≤ 10μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 3000 | 0.39 | Binding ≤ 10μM |
ADA2C_RAT | P22086 | Alpha-2c Adrenergic Receptor, Rat | 3000 | 0.39 | Binding ≤ 10μM |
ADRB1_HUMAN | P08588 | Beta-1 Adrenergic Receptor, Human | 1500 | 0.41 | Binding ≤ 10μM |
ADRB2_HUMAN | P07550 | Beta-2 Adrenergic Receptor, Human | 1200 | 0.41 | Binding ≤ 10μM |
DRD1_HUMAN | P21728 | Dopamine D1 Receptor, Human | 1200 | 0.41 | Binding ≤ 10μM |
DRD1_PIG | P50130 | Dopamine D1 Receptor, Pig | 21 | 0.54 | Binding ≤ 10μM |
DRD1_RAT | P18901 | Dopamine D1 Receptor, Rat | 100 | 0.49 | Binding ≤ 10μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 107 | 0.49 | Binding ≤ 10μM |
DRD2_HUMAN | P14416 | Dopamine D2 Receptor, Human | 1520 | 0.41 | Binding ≤ 10μM |
DRD3_RAT | P19020 | Dopamine D3 Receptor, Rat | 170 | 0.47 | Binding ≤ 10μM |
DRD4_RAT | P30729 | Dopamine D4 Receptor, Rat | 13 | 0.55 | Binding ≤ 10μM |
DRD5_RAT | P25115 | Dopamine D5 Receptor, Rat | 16 | 0.55 | Binding ≤ 10μM |
5HT2C_RAT | P08909 | Serotonin 2c (5-HT2c) Receptor, Rat | 2400 | 0.39 | Binding ≤ 10μM |
ADCY5_RAT | Q04400 | Adenylate Cyclase Type V, Rat | 51 | 0.51 | Functional ≤ 10μM |
DRD1_CARAU | P35406 | Dopamine D1 Receptor, Carau | 88 | 0.49 | Functional ≤ 10μM |
DRD1_HUMAN | P21728 | Dopamine D1 Receptor, Human | 14 | 0.55 | Functional ≤ 10μM |
DRD1_RAT | P18901 | Dopamine D1 Receptor, Rat | 10000 | 0.35 | Functional ≤ 10μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 70 | 0.50 | Functional ≤ 10μM |
DRD4_HUMAN | P21917 | Dopamine D4 Receptor, Human | 17 | 0.54 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 10000 | 0.35 | Functional ≤ 10μM |
Description | Species |
---|---|
Adenylate cyclase activating pathway | |
Adenylate cyclase inhibitory pathway | |
Adrenaline signalling through Alpha-2 adrenergic receptor | |
Adrenaline,noradrenaline inhibits insulin secretion | |
Adrenoceptors | |
Dopamine receptors | |
G alpha (i) signalling events | |
G alpha (s) signalling events | |
G alpha (z) signalling events | |
Glucagon signaling in metabolic regulation | |
PKA activation | |
PKA activation in glucagon signalling | |
Vasopressin regulates renal water homeostasis via Aquaporins |